I Stock

Summary

Country: Germany

Publications

  1. ncbi request reprint Natural antimicrobial susceptibilities and biochemical profiles of Yersinia enterocolitica-like strains: Y. frederiksenii, Y. intermedia, Y. kristensenii and Y. rohdei
    Ingo Stock
    Institute of Medical Microbiology and Immunology, Pharmaceutical Microbiology, Rheinische Friedrich Wilhelm Universität, Meckenheimer Allee 168, 53115 Bonn, Germany
    FEMS Immunol Med Microbiol 38:139-52. 2003
  2. ncbi request reprint [West nile virus. An unusual flavivirus with increased importance]
    Ingo Stock
    Institut fur Medizinische Mikrobiologie und Immunologie, Pharmazeutische Mikrobiologie, Universitat Bonn
    Med Monatsschr Pharm 27:112-20; quiz 121-2. 2004
  3. ncbi request reprint ["New" coronaviruses are the cause of respiratory diseases]
    Ingo Stock
    Med Monatsschr Pharm 29:417. 2006
  4. ncbi request reprint [Antimycotic therapy of Tinea pedis and other foot mycoses]
    Ingo Stock
    Med Monatsschr Pharm 31:247-56; quiz 257-8. 2008
  5. ncbi request reprint Natural antimicrobial susceptibilities of strains of 'unusual' Serratia species: S. ficaria, S. fonticola, S. odorifera, S. plymuthica and S. rubidaea
    Ingo Stock
    Institut fur Medizinische Mikrobiologie und Immunologie, Pharmazeutische Mikrobiologie, Meckenheimer Allee 168, University of Bonn, D 53115 Bonn, Germany
    J Antimicrob Chemother 51:865-85. 2003
  6. ncbi request reprint [Hand, foot and mouth disease--more than a harmless "childhood disease"]
    Ingo Stock
    Institut for Medizinische Mikrobiologie, Immunologie und Parasitologie, Abteilung Pharmazeutische Mikrobiologie, Universitat Bonn, Meckenheimer Allee 168, 53115 Bonn
    Med Monatsschr Pharm 37:4-10; quiz 11-2. 2014
  7. ncbi request reprint [Infectious mononucleosis--a "childhood disease" of great medical concern]
    Ingo Stock
    Institut fur Medizinische Mikrobiologie, Immunologie und Parasitologie, Abteilung Pharmazeutische Mikrobiologie, Universitat Bonn, Meckenheimer Allee 168, 53115 Bonn
    Med Monatsschr Pharm 36:364-8. 2013
  8. ncbi request reprint [Molluscum contagiosum--a common but poorly understood "childhood disease" and sexually transmitted illness]
    Ingo Stock
    Institut fur Medizinische Mikrobiologie, Immunologie und Parasitologie, Abteilung Pharmazeutische Mikrobiologie, Universitat Bonn, Bonn
    Med Monatsschr Pharm 36:282-90. 2013
  9. ncbi request reprint [Infections with Chlamydia trachomatis]
    Ingo Stock
    Institut fur Medizinische Mikrobiologie, Immunologie und Parasitologie, Abteilung Pharmazeutische Mikrobiologie, Universitat Bonn, Meckenheimer Allee 168, 53115 Bonn
    Med Monatsschr Pharm 35:209-22; quiz 223-4. 2012
  10. ncbi request reprint [Special characteristics of antibiotic therapy in the elderly]
    Ingo Stock
    Institut fur Medizinische Mikrobiologie, Immunologie und Parasitologie, Abteilung Pharmazeutische Mikrobiologie, Universitat Bonn, Meckenheimer Allee 168, 53115 Bonn
    Med Monatsschr Pharm 35:84-92; quiz 93-4. 2012

Collaborators

Detail Information

Publications49

  1. ncbi request reprint Natural antimicrobial susceptibilities and biochemical profiles of Yersinia enterocolitica-like strains: Y. frederiksenii, Y. intermedia, Y. kristensenii and Y. rohdei
    Ingo Stock
    Institute of Medical Microbiology and Immunology, Pharmaceutical Microbiology, Rheinische Friedrich Wilhelm Universität, Meckenheimer Allee 168, 53115 Bonn, Germany
    FEMS Immunol Med Microbiol 38:139-52. 2003
    ..An evaluation of 30 biochemical tests that secured phenotypic identification to the Yersinia species level is presented...
  2. ncbi request reprint [West nile virus. An unusual flavivirus with increased importance]
    Ingo Stock
    Institut fur Medizinische Mikrobiologie und Immunologie, Pharmazeutische Mikrobiologie, Universitat Bonn
    Med Monatsschr Pharm 27:112-20; quiz 121-2. 2004
  3. ncbi request reprint ["New" coronaviruses are the cause of respiratory diseases]
    Ingo Stock
    Med Monatsschr Pharm 29:417. 2006
  4. ncbi request reprint [Antimycotic therapy of Tinea pedis and other foot mycoses]
    Ingo Stock
    Med Monatsschr Pharm 31:247-56; quiz 257-8. 2008
    ..For systemic treatment, systemically applicable azole antifungals (fluconazole, itraconazole), terbinafine and griseofulvine are in use...
  5. ncbi request reprint Natural antimicrobial susceptibilities of strains of 'unusual' Serratia species: S. ficaria, S. fonticola, S. odorifera, S. plymuthica and S. rubidaea
    Ingo Stock
    Institut fur Medizinische Mikrobiologie und Immunologie, Pharmazeutische Mikrobiologie, Meckenheimer Allee 168, University of Bonn, D 53115 Bonn, Germany
    J Antimicrob Chemother 51:865-85. 2003
    ..fonticola, also a species-specific class A beta-lactamase. Inducibility of these enzymes was shown in all species with the exception of S. rubidaea and four of five strains of S. plymuthica...
  6. ncbi request reprint [Hand, foot and mouth disease--more than a harmless "childhood disease"]
    Ingo Stock
    Institut for Medizinische Mikrobiologie, Immunologie und Parasitologie, Abteilung Pharmazeutische Mikrobiologie, Universitat Bonn, Meckenheimer Allee 168, 53115 Bonn
    Med Monatsschr Pharm 37:4-10; quiz 11-2. 2014
    ..In the last years, several novel agents with good in vitro and in vivo activity against enteroviruses have been developed. A vaccine against HFMD is not yet available...
  7. ncbi request reprint [Infectious mononucleosis--a "childhood disease" of great medical concern]
    Ingo Stock
    Institut fur Medizinische Mikrobiologie, Immunologie und Parasitologie, Abteilung Pharmazeutische Mikrobiologie, Universitat Bonn, Meckenheimer Allee 168, 53115 Bonn
    Med Monatsschr Pharm 36:364-8. 2013
    ..At least 90% of all adults are seropositive to EBV. The treatment of infectious mononucleosis is mainly symptomatic, a generally effective specific therapy does not exist. A vaccine is currently not available...
  8. ncbi request reprint [Molluscum contagiosum--a common but poorly understood "childhood disease" and sexually transmitted illness]
    Ingo Stock
    Institut fur Medizinische Mikrobiologie, Immunologie und Parasitologie, Abteilung Pharmazeutische Mikrobiologie, Universitat Bonn, Bonn
    Med Monatsschr Pharm 36:282-90. 2013
    ..Effective prevention is problematic due to the high infectivity of the virus. A vaccine is not available...
  9. ncbi request reprint [Infections with Chlamydia trachomatis]
    Ingo Stock
    Institut fur Medizinische Mikrobiologie, Immunologie und Parasitologie, Abteilung Pharmazeutische Mikrobiologie, Universitat Bonn, Meckenheimer Allee 168, 53115 Bonn
    Med Monatsschr Pharm 35:209-22; quiz 223-4. 2012
    ..This strategy includes therapeutic and hygienic measures that may be suitable to eliminate one of the leading causes of blindness worldwide...
  10. ncbi request reprint [Special characteristics of antibiotic therapy in the elderly]
    Ingo Stock
    Institut fur Medizinische Mikrobiologie, Immunologie und Parasitologie, Abteilung Pharmazeutische Mikrobiologie, Universitat Bonn, Meckenheimer Allee 168, 53115 Bonn
    Med Monatsschr Pharm 35:84-92; quiz 93-4. 2012
    ..Since older people often take several drugs simultaneously, the probability for the occurrence of side effects and drug interactions in this population is greatly increased. Significant compliance problems may also arise...
  11. ncbi request reprint [Rubella (German measles)--still a major infectious disease]
    Ingo Stock
    Institut fur Medizinische Mikrobiologie, Immunologie und Parasitologie, Abteilung Pharmazeutische Mikrobiologie, Universitat Bonn, Meckenheimer Allee 168, 53115 Bonn
    Med Monatsschr Pharm 35:14-22; quiz 23-4. 2012
    ..Nevertheless, rubella is still widespread in some countries, and still occurs in Germany. Postnatal rubella virus infections can be treated symptomatically. A specific (antiviral) therapy is not available...
  12. ncbi request reprint [Mumps--infectious disease with various faces]
    Ingo Stock
    Med Monatsschr Pharm 30:249-56; quiz 257-8. 2007
    ..Young adults have been most frequently affected. The lack of immunity in this population is likely to be responsible for the increasing number of mumps cases...
  13. ncbi request reprint [Human influenza]
    Ingo Stock
    Med Monatsschr Pharm 29:360-8; quiz 369-70. 2006
    ..The virus type of the new pandemic is still uncertain and it is also unclear, if a pandemic spread of the virus may be prevented by consistent controlling of avian influenza...
  14. ncbi request reprint [Illnesses by the human respiratory syncytial virus]
    Ingo Stock
    Med Monatsschr Pharm 29:329-34, 335-6. 2006
    ..Current guidelines do no contain specific recommendations for the causal treatment of HRSV infections. Immunoprophylactic and hygienic measures represent the most effective strategies for prevention of disease...
  15. ncbi request reprint [Pertussis--not only a childhood disease]
    Ingo Stock
    Med Monatsschr Pharm 29:206-14; quiz 215-6. 2006
    ..Macrolides are regarded to be the treatment of choice for the management of B. pertussis infections. Active immunization with whole cell and in particular acellular vaccines is the mainstay for prevention of disease...
  16. ncbi request reprint [Lymphogranuloma venereum. Expansion of a tropical sexual disease into Europe]
    Ingo Stock
    Med Monatsschr Pharm 29:65-70. 2006
  17. ncbi request reprint [Venereal syphilis. "Return" of an old infectious disease]
    Ingo Stock
    Med Monatsschr Pharm 28:338-48; quiz 349-50. 2005
  18. ncbi request reprint [Norovirus infections]
    Ingo Stock
    Med Monatsschr Pharm 30:362-70; quiz 371-2. 2007
    ..Because of the high stability of noroviruses to several environmental conditions, disinfection should be performed applying disinfectants with proven activity against noroviruses...
  19. ncbi request reprint [Hantavirus infections]
    Ingo Stock
    Med Monatsschr Pharm 31:127-36; quiz 137-8. 2008
    ..In Germany, there is no licensed vaccine applicable for the prevention of hantavirus diseases. Anti-infectious measures are, therefore, regarded to be the most effective strategy to prevent illnesses due to these emerging RNA viruses...
  20. ncbi request reprint [Chikungunya fever--expanded distribution of a re-emerging tropical infectious disease]
    Ingo Stock
    Med Monatsschr Pharm 32:17-26. 2009
    ..During the last decades, A. albopictus mosquitos have been spread into several temperate regions and are now widely distributed in several areas of South and Central Europe and North America...
  21. ncbi request reprint [Measles]
    Ingo Stock
    Med Monatsschr Pharm 32:118-26; quiz 127-8. 2009
    ....
  22. ncbi request reprint [Antimycotic therapy of Tinea unguium and other onychomycoses]
    Ingo Stock
    Med Monatsschr Pharm 32:289-98; quiz 299-300. 2009
    ..An improved effectiveness of systematic treatment is also achieved by concomitant application of topical antifungals...
  23. ncbi request reprint [Streptococcus pyogenes--much more than the aetiological agent of scarlet fever]
    Ingo Stock
    Med Monatsschr Pharm 32:408-16; quiz 417-8. 2009
    ..Because of the wide distribution of S. pyogenes in the general population and the lack of an effective vaccine, possibilities for prevention allowing a suitable protection for diseases due to S. pyogenes are very limited...
  24. ncbi request reprint [Fungal diseases of vulva and vagina caused by Candida species]
    Ingo Stock
    Med Monatsschr Pharm 33:324-33; quiz 335-6. 2010
    ..Significance of non-conventional and adjuvant therapeutic approaches is considered to be generally low...
  25. ncbi request reprint [Rotavirus infections]
    Ingo Stock
    Med Monatsschr Pharm 34:4-13; quiz 15-6. 2011
    ..In Germany, two efficient and secure live vaccines against rotaviruses have been approved. Their application, however, is not generally recommended...
  26. ncbi request reprint [Infections with human immunodeficiency viruses. Part II: Antiretroviral drugs, therapeutic options, and diagnostics]
    Ingo Stock
    Institut fur Medizinische Mikrobiologie, Immunologie und Parasitologie, Abteilung Pharmazeutische Mikrobiologie, Universitat Bonn, Meckenheimer Allee 168, 53115 Bonn
    Med Monatsschr Pharm 34:234-44; quiz 245-6. 2011
    ..Diagnostics of HIV infection is based upon the proof of specific antibodies...
  27. ncbi request reprint Natural antimicrobial susceptibility patterns of Kluyvera ascorbata and Kluyvera cryocrescens strains and review of the clinical efficacy of antimicrobial agents used for the treatment of Kluyvera infections
    I Stock
    Rheinische Friedrich Wilhelm Universität Bonn, Institut fur Medizinische Mikrobiologie und Immunologie, Pharmazeutische Mikrobiologie, Bonn, Germany
    J Chemother 17:143-60. 2005
    ..ascorbata from K. cryocrescens, they do not allow a separation of these species. The literature dealing with the clinical efficacy of antimicrobial agents used for the treatment of Kluyvera infections is discussed...
  28. ncbi request reprint Natural antimicrobial susceptibility patterns and biochemical identification of Escherichia albertii and Hafnia alvei strains
    Ingo Stock
    Pharmaceutical Microbiology, Institute of Medical Microbiology and Immunology, University of Bonn, 53115 Bonn, Germany
    Diagn Microbiol Infect Dis 51:151-63. 2005
    ..albertii from those of the H. alvei complex. Although out of the scope of this study, it should be noted that several strains of E. albertii showed acquired resistances to some penicillins and antifolates...
  29. ncbi request reprint Natural antibiotic susceptibility of Proteus spp., with special reference to P. mirabilis and P. penneri strains
    I Stock
    Rheinische Friedrich Wilhelm Universität Bonn, Institut fur Medizinische Mikrobiologie und Immunologie, Pharmazeutische Mikrobiologie, Bonn, Germany
    J Chemother 15:12-26. 2003
    ..Natural susceptibility patterns are compared with those of a recent study, dealing with natural susceptibilities of species of the P. vulgaris complex...
  30. ncbi request reprint [Infections with human immunodeficiency viruses. Part I: pathogens, epidemiology, and clinical presentation]
    Ingo Stock
    Institut fur Medizinische Mikrobiologie, Immunologie und Parasitologie, Abteilung Pharmazeutische Mikrobiologie, Universitat Bonn, Meckenheimer Allee 168, 53115 Bonn
    Med Monatsschr Pharm 34:190-8; quiz 199-200. 2011
    ..In several less developed regions, these so-called AIDS-defining diseases still represent one of the most frequent causes of death...
  31. ncbi request reprint Natural antibiotic susceptibility of strains of Serratia marcescens and the S. liquefaciens complex: S. liquefaciens sensu stricto, S. proteamaculans and S. grimesii
    I Stock
    Institut fur Medizinische Mikrobiologie und Immunologie, Pharmazeutische Mikrobiologie, Universitat Bonn, Meckenheimer Allee 168, D 53115 Bonn, Germany
    Int J Antimicrob Agents 22:35-47. 2003
    ..marcescens aminoglycoside 6'-acetyltransferase AAC(6')-Ic and its absence in other Serratia spp. was supported by the data. All species of the S. liquefaciens complex should be considered as probable agents of human diseases...
  32. ncbi request reprint Natural antibiotic susceptibility of Ewingella americana strains
    I Stock
    Rheinische Friedrich Wilhelm Universität Bonn, Institut fur Medizinische Mikrobiologie und Immunologie, Pharmazeutische Mikrobiologie, Bonn, Germany
    J Chemother 15:428-41. 2003
    ..It enlarges the number of Enterobacteriaceae expressing naturally-occurring AmpC beta-lactamases...
  33. ncbi request reprint [Tuberculosis. An old infectious disease with new problems]
    Ingo Stock
    Med Monatsschr Pharm 28:45-52; quiz 53-4. 2005
  34. ncbi request reprint Antimicrobial susceptibility patterns, beta-lactamases, and biochemical identification of Yokenella regensburgei strains
    Ingo Stock
    Institute of Medical Microbiology and Immunology, University of Bonn, Bonn, Germany
    Diagn Microbiol Infect Dis 48:5-15. 2004
    ..Hydroxyproline amidase, maltosidase, tri-peptidase, proline deaminase, catalase reaction, Voges-Proskauer test, and fermentation of glycerol, melibiose and myo-inositol were suitable parameters to separate Y. regensburgei from H. alvei...
  35. ncbi request reprint Natural antimicrobial susceptibility patterns and biochemical profiles of Leclercia adecarboxylata strains
    I Stock
    Institute of Medical Microbiology and Immunology, Pharmaceutical Microbiology, University of Bonn, D 53115 Bonn, Germany
    Clin Microbiol Infect 10:724-33. 2004
    ..Special attention should be paid to biochemically aberrant leclerciae. Apart from biochemical features, fosfomycin susceptibility might be useful to differentiate between L. adecarboxylata and E. coli...
  36. ncbi request reprint [Treatment for malaria]
    Ingo Stock
    Med Monatsschr Pharm 27:260-72; quiz 273-4. 2004
  37. ncbi request reprint Natural antimicrobial susceptibilities of Plesiomonas shigelloides strains
    I Stock
    Institut fur Medizinische Mikrobiologie und Immunologie, Pharmazeutische Mikrobiologie, University of Bonn, Meckenheimer Allee 168, D 53115 Bonn, Germany
    J Antimicrob Chemother 48:803-11. 2001
    ..A database is described of the natural susceptibility of P. shigelloides strains to a wide range of antibiotics. It can be used for the validation of susceptibility test results of these bacteria...
  38. ncbi request reprint Natural antibiotic susceptibility of strains of the Enterobacter cloacae complex
    I Stock
    Institut fur Medizinische Mikrobiologie und Immunologie, Pharmazeutische Mikrobiologie, Universitat Bonn, Meckenheimer Allee 168, D 53115, Bonn, Germany
    Int J Antimicrob Agents 18:537-45. 2001
    ..Enterobacter hormaechei was the species most susceptible to fosfomycin. beta-Lactam susceptibility patterns pointed to the presence of chromosomally-encoded AmpC enzymes in all taxa of the E. cloacae complex...
  39. ncbi request reprint Natural antibiotic susceptibility of Enterobacter spp., with special reference to Enterobacter aerogenes and Enterobacter intermedius strains
    I Stock
    Rheinische Friedrich Wilhelm Universität, Institut fur Medizinische Mikrobiologie und Immunologie, Pharmazeutische Mikrobiologie, Bonn, Germany
    J Chemother 14:444-60. 2002
    ..The naturally-expressed amount of enzyme depends on the species...
  40. pmc Natural antibiotic susceptibilities of Edwardsiella tarda, E. ictaluri, and E. hoshinae
    I Stock
    Institute of Medical Microbiology and Immunology, Pharmaceutical Microbiology, University of Bonn, Bonn, Germany
    Antimicrob Agents Chemother 45:2245-55. 2001
    ..The present study describes a database concerning the natural susceptibility of Edwardsiella species to a wide range of antibiotics, which can be applied to validate forthcoming antibiotic susceptibility tests of these microorganisms...
  41. ncbi request reprint Natural antibiotic susceptibility of Rahnella aquatilis and R. aquatilis-related strains
    I Stock
    Pharmaceutical Microbiology, University of Bonn, Germany
    J Chemother 12:30-9. 2000
    ..Under the conditions described pyrase might be a parameter to differentiate strains of Rahnella genomovars 1 and 2...
  42. ncbi request reprint Natural antibiotic susceptibility of Klebsiella pneumoniae, K. oxytoca, K. planticola, K. ornithinolytica and K. terrigena strains
    I Stock
    Institut fur Medizinische Mikrobiologie und Immunologie, Pharmazeutische Mikrobiologie, Universitat Bonn, Germany
    J Med Microbiol 50:396-406. 2001
    ..pneumoniae. Similar natural susceptibility patterns of K. planticola and K. ornithinolytica to all tested antibiotics support the status of K. ornithinolytica as a biovar of K. planticola...
  43. ncbi request reprint Natural antibiotic susceptibility of Salmonella enterica strains
    I Stock
    Institut fur Medizinische Mikrobiologie und Immunologie, Pharmazeutische Mikrobiologie, Meckenheimer Allee 168, D 53115, Bonn, Germany
    Int J Antimicrob Agents 16:211-7. 2000
    ..A database of the antibiotic susceptibility of S. enterica was set up. It may be of use to validate antibiotic susceptibility test results of these bacteria...
  44. ncbi request reprint Natural antibiotic susceptibility of Enterobacter amnigenus, Enterobacter cancerogenus, Enterobacter gergoviae and Enterobacter sakazakii strains
    I Stock
    Universitat Bonn, Institut fur Medizinische Mikrobiologie und Immunologie, Pharmazeutische Mikrobiologie, Meckenheimer Allee 168, D 53115 Bonn, Germany
    Clin Microbiol Infect 8:564-78. 2002
    ..To investigate the natural susceptibility to 69 antimicrobial agents of 107 Enterobacter strains comprising E. amnigenus (n = 18), E. cancerogenus (n = 26), E. gergoviae (n = 28) and E. sakazakii (n = 35)...
  45. ncbi request reprint [Coronaviruses. Causes of SARS and other infections]
    Ingo Stock
    Institut fur Medizinische Mikrobiologie und Immunologie, Pharmazeutische Mikrobiologie, Universitat Bonn, Meckenheimer Allee 168, 53115 Bonn
    Med Monatsschr Pharm 27:4-12. 2004
  46. ncbi request reprint Moellerella wisconsensis: identification, natural antibiotic susceptibility and its dependency on the medium applied
    Ingo Stock
    Institute of Medical Microbiology and Immunology, Pharmaceutical Microbiology, University of Bonn, Bonn, Germany
    Diagn Microbiol Infect Dis 45:1-11. 2003
    ..From the data of the present study it is possible that some moellerellae are misidentified as Klebsiella pneumoniae subsp. ozaenae...
  47. ncbi request reprint Biochemical and genetic characterization of the beta-lactamases of Y. aldovae, Y. bercovieri, Y. frederiksenii and "Y. ruckeri" strains
    Andrea Maria Schiefer
    Rheinische Friedrich Wilhelm Universität Bonn, Institut fur Medizinische Mikrobiologie und Immunologie, Pharmazeutische Mikrobiologie, Bonn, Germany
    Int J Antimicrob Agents 25:496-500. 2005
    ..Beta-lactamases of Y. aldovae and "Y. ruckeri" have been characterized for the first time...
  48. ncbi request reprint beta-Lactam-susceptibility patterns of Plesiomonas shigelloides strains: importance of inoculum and medium
    I Stock
    Pharmazeutische Mikrobiologie, , Germany
    Scand J Infect Dis 33:692-6. 2001
    ..The potential to be resistant to a variety of beta-lactams under conceivable testing conditions should question the use of numerous beta-lactams for the treatment of Plesiomonas infections...
  49. ncbi request reprint Natural antibiotic susceptibility and biochemical profiles of Yersinia enterocolitica-like strains: Y. bercovieri, Y. mollaretii, Y. aldovae and 'Y. ruckeri'
    Ingo Stock
    Institute of Medical Microbiology and Immunology, Pharmaceutical Microbiology, University of Bonn, Germany
    J Med Microbiol 51:56-69. 2002
    ..aldovae and 'Y. ruckeri' strains express no, or only small amounts, of enzyme. An evaluation of 30 biochemical tests that determined phenotypic identification to the Yersinia species level is presented...